{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T11:03:32Z","timestamp":1789556612187,"version":"build-2803163510"},"reference-count":93,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:00:00Z","timestamp":1789516800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>G protein-coupled receptor 183 (GPR183; also known as EBI2, Epstein-Barr virus-induced G-protein-coupled receptor 2) has emerged as a central regulator linking 7\u03b1,25-dihydroxycholesterol (7\u03b1,25-OHC) gradients to immune cell trafficking and tissue organization. In this review, we synthesize the structural, physiological, and oncogenic dimensions of the GPR183 axis. We first discuss the enzymatic biogenesis of its oxysterol ligand and the structural mechanisms underlying receptor activation. We then examine the context-dependent roles of GPR183 within the tumor microenvironment (TME), including receptor antagonism in hematological malignancies, modulation of immune organization in immunologically cold solid tumors. We further review the emerging relevance of spatial GPR183 profiling in relation to immune checkpoint blockade (ICB) responsiveness, as well as recent synthetic immunology strategies aimed at enhancing chimeric antigen receptor T (CAR-T) cell trafficking through oxysterol sensing. We identify and systematically analyze the central paradox of the GPR183 axis \u2014 namely, that identical 7\u03b1,25-OHC gradients can drive either anti-tumor tertiary lymphoid structure (TLS) formation or pro-tumor immunosuppressive myeloid cell recruitment \u2014 and discuss the potential determinants of this contextual polarity, including ligand concentration thresholds, spatial compartmentalization of oxysterol production, and receptor co-expression patterns. Collectively, current advances in the GPR183-oxysterol axis delineate new opportunities for metabolism-oriented immunotherapy and precision oncology.<\/jats:p>","DOI":"10.3389\/fimmu.2026.1931992","type":"journal-article","created":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T10:18:33Z","timestamp":1789553913000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["The GPR183-oxysterol axis in cancer: immune trafficking, spatial organization, and therapeutic potential"],"prefix":"10.3389","volume":"17","author":[{"given":"Haihui","family":"Zhuang","sequence":"first","affiliation":[{"name":"Department of Hematology, The Affiliated People\u2019s Hospital of Ningbo University","place":["Ningbo, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fenglin","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Hematology, The Affiliated People\u2019s Hospital of Ningbo University","place":["Ningbo, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuangyue","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Hematology, The Affiliated People\u2019s Hospital of Ningbo University","place":["Ningbo, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Hematology, The Affiliated People\u2019s Hospital of Ningbo University","place":["Ningbo, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjie","family":"Sha","sequence":"additional","affiliation":[{"name":"Department of Hematology, The Affiliated People\u2019s Hospital of Ningbo University","place":["Ningbo, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renzhi","family":"Pei","sequence":"additional","affiliation":[{"name":"Department of Hematology, The Affiliated People\u2019s Hospital of Ningbo University","place":["Ningbo, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Hematology, The Affiliated People\u2019s Hospital of Ningbo University","place":["Ningbo, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Lu","sequence":"additional","affiliation":[{"name":"Department of Hematology, The Affiliated People\u2019s Hospital of Ningbo University","place":["Ningbo, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,16]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1186\/s13578-025-01398-7","article-title":"The regulatory functions of G protein-coupled receptors signaling pathways in B cell differentiation and development contributing to autoimmune diseases","volume":"15","author":"Shao","year":"2025","journal-title":"Cell Bioscience"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2009.06.016","article-title":"Guidance of B cells by the orphan G protein-coupled receptor EBI2 shapes humoral immune responses","volume":"31","author":"Gatto","year":"2009","journal-title":"Immunity"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.biochi.2018.04.014","article-title":"EBI2\u2013Sensor for dihydroxycholesterol gradients in neuroinflammation","volume":"153","author":"Kurschus","year":"2018","journal-title":"Biochimie"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2012.06.015","article-title":"Oxysterol gradient generation by lymphoid stromal cells guides activated B cell movement during humoral responses","volume":"37","author":"Yi","year":"2012","journal-title":"Immunity"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.7554\/elife.00757","article-title":"EBI2-mediated bridging channel positioning supports splenic dendritic cell homeostasis and particulate antigen capture","volume":"2","author":"Yi","year":"2013","journal-title":"Elife"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1002\/jlb.2vmr1217-510r","article-title":"EBI2 in splenic and local immune responses and in autoimmunity","volume":"104","author":"Barington","year":"2018","journal-title":"J Leukocyte Biol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1111\/bph.15311","article-title":"The oxysterol receptor GPR183 in inflammatory bowel diseases","volume":"178","author":"Misselwitz","year":"2021","journal-title":"Br J Pharmacol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1038\/s41385-019-0140-x","article-title":"The EBI2-oxysterol axis promotes the development of intestinal lymphoid structures and colitis","volume":"12","author":"Wyss","year":"2019","journal-title":"Mucosal Immunol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1097\/HEP.0000000000000520","article-title":"A multisociety Delphi consensus statement on new fatty liver disease nomenclature","volume":"78","author":"Rinella","year":"2023","journal-title":"Hepatology"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2012.12.001","article-title":"Oxysterols in the pathogenesis of major chronic diseases","volume":"1","author":"Poli","year":"2013","journal-title":"Redox Biol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-018-0044-z","article-title":"The immunology of hepatocellular carcinoma","volume":"19","author":"Ringelhan","year":"2018","journal-title":"Nat Immunol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1126\/science.1254790","article-title":"25-Hydroxycholesterol suppresses interleukin-1\u2013driven inflammation downstream of type I interferon","volume":"345","author":"Reboldi","year":"2014","journal-title":"Science"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20130440","article-title":"The oxysterol\u2013CXCR2 axis plays a key role in the recruitment of tumor-promoting neutrophils","volume":"210","author":"Raccosta","year":"2013","journal-title":"J Exp Med"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1007\/s10528-025-11026-1","article-title":"High expression of GPR183 predicts poor survival in cytogenetically normal acute myeloid leukemia","volume":"64","author":"Zhuang","year":"2025","journal-title":"Biochem Genet"},{"key":"B15","doi-asserted-by":"publisher","first-page":"6043","DOI":"10.1182\/blood-2023-185692","article-title":"G protein-coupled receptor 183 plays a prognostic factor in acute myeloid leukemia by regulating immune regulation","volume":"142","author":"Li","year":"2023","journal-title":"Blood"},{"key":"B16","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1007\/s10585-025-10360-3","article-title":"G-protein coupled receptor 183 (GPR183) inhibits visceral metastasis of non-small cell lung cancer","volume":"42","author":"Cheng","year":"2025","journal-title":"Clin Exp Metastasis"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-026-02642-5","article-title":"GPR183 potentiates CAR-T cell infiltration and antitumor immunity through a positive feedback loop involving the oxysterol 7\u03b1, 25-OHC","volume":"25","author":"Guo","year":"2026","journal-title":"Mol Cancer"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-026-02473-y","article-title":"Engineering NK and T cells with metabolite-sensing receptors to target solid tumors","volume":"27","author":"Kim","year":"2026","journal-title":"Nat Immunol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/s1388-1981(00)00142-6","article-title":"Oxysterol biosynthetic enzymes","volume":"1529","author":"Russell","year":"2000","journal-title":"Biochim Biophys Acta (BBA)-Molecular Cell Biol Lipids"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2020.100983","article-title":"Cholesterol 25-hydroxylase (CH25H) as a promoter of adipose tissue inflammation in obesity and diabetes","volume":"39","author":"Russo","year":"2020","journal-title":"Mol Metab"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.0610318","article-title":"Cholesterol 25-hydroxylase production by dendritic cells and macrophages is regulated by type I interferons","volume":"88","author":"Park","year":"2010","journal-title":"J Leukocyte Biol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"2044","DOI":"10.7150\/ijbs.92274","article-title":"Cholesterol metabolism in tumor microenvironment: cancer hallmarks and therapeutic opportunities","volume":"20","author":"Jiang","year":"2024","journal-title":"Int J Biol Sci"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1038\/s41467-025-55969-w","article-title":"Lymphatic-derived oxysterols promote anti-tumor immunity and response to immunotherapy in melanoma","volume":"16","author":"Sun","year":"2025","journal-title":"Nat Commun"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.str.2022.04.006","article-title":"Structures of oxysterol sensor EBI2\/GPR183, a key regulator of the immune response","volume":"30","author":"Chen","year":"2022","journal-title":"Structure"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1039\/D2SC05962B","article-title":"Ligand entry pathways control the chemical space recognized by GPR183","volume":"14","author":"Kj\u00e6r","year":"2023","journal-title":"Chem Sci"},{"key":"B26","first-page":"2025.2006. 2019.659764","article-title":"AI-driven virtual screening and first-in-class conformational biosensor enable the discovery of a GPR183 inverse agonist","volume-title":"Biorxiv","author":"Andersson","year":"2025"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.3c01905","article-title":"Discovery of a highly potent oxysterol receptor GPR183 antagonist bearing the benzo [d] thiazole structural motif for the treatment of inflammatory bowel disease (IBD)","volume":"67","author":"Zeng","year":"2024","journal-title":"J Med Chem"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jpcb.4c02812","article-title":"Exploring the activation mechanism of the GPR183 receptor","volume":"128","author":"Hu","year":"2024","journal-title":"J Phys Chem B"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201608-1580oc","article-title":"Epstein-Barr virus\u2013induced gene 2 mediates allergen-induced leukocyte migration into airways","volume":"195","author":"Shen","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2015.00060","article-title":"7\u03b1, 25-dihydroxycholesterol-mediated activation of EBI2 in immune regulation and diseases","volume":"6","author":"Sun","year":"2015","journal-title":"Front Pharmacol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2019.01.031","article-title":"Single-cell RNA-seq reveals AML hierarchies relevant to disease progression and immunity","volume":"176","author":"Van Galen","year":"2019","journal-title":"Cell"},{"key":"B32","first-page":"2519","article-title":"Bone marrow stroma protects FLT3 acute myeloid leukemia (AML) through CYP3A4-mediated drug metabolization of FLT3 tyrosine kinase inhibitors (TKIs)","volume":"130","author":"Chang","year":"2017","journal-title":"Blood"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1172\/jci68101","article-title":"Positive feedback between NF-\u03baB and TNF-\u03b1 promotes leukemia-initiating cell capacity","volume":"124","author":"Kagoya","year":"2014","journal-title":"J Clin Invest"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.2217\/fon.09.72","article-title":"NF-\u03baB as a prognostic marker and therapeutic target in chronic lymphocytic leukemia","volume":"5","author":"Pepper","year":"2009","journal-title":"Future Oncol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-60761-384-8_7","article-title":"Expression of constitutively active nuclear-\u03baB RelA transcription factor in blasts of acute myeloid leukemia","volume":"35","author":"Bueso-Ramos","year":"2004","journal-title":"Hum Pathol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-025-02645-z","article-title":"Targeting lipid metabolism in acute myeloid leukemia: biological insights and therapeutic opportunities: ACUTE MYELOID LEUKEMIA","volume":"39","author":"Dembitz","year":"2025","journal-title":"Leukemia"},{"key":"B37","doi-asserted-by":"publisher","first-page":"3557","DOI":"10.3390\/cancers14143557","article-title":"NF-\u03baB: a druggable target in acute myeloid leukemia","volume":"14","author":"Di Francesco","year":"2022","journal-title":"Cancers"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15030835","article-title":"The immunology of DLBCL","volume":"15","author":"Takahara","year":"2023","journal-title":"Cancers"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-02-697185","article-title":"EBI2 overexpression in mice leads to B1 B-cell expansion and chronic lymphocytic leukemia\u2013like B-cell Malignancies","volume":"129","author":"Niss Arfelt","year":"2017","journal-title":"Blood J Am Soc Hematol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1146\/annurev-immunol-020711-075027","article-title":"Pathogenesis of human B cell lymphomas","volume":"30","author":"Shaffer","year":"2012","journal-title":"Annu Rev Immunol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1038\/nature08226","article-title":"EBI2 mediates B cell segregation between the outer and centre follicle","volume":"460","author":"Pereira","year":"2009","journal-title":"Nature"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2022.872001","article-title":"Immunophenotypic landscape and prognosis-related mRNA signature in diffuse large B cell lymphoma","volume":"13","author":"Jiang","year":"2022","journal-title":"Front Genet"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.21203\/rs.3.rs-42118\/v1","article-title":"A Pan-cancer analysis of GPR183 correlated with tumor immunity","author":"Yang","year":"2020"},{"key":"B44","first-page":"2026.2001. 2031.701004","article-title":"Single-cell profiling of synchronous multi-organ metastasis reveals a systemic CD74+ lipid-associated macrophage niche driving polymetastatic breast cancer","volume-title":"Biorxiv","author":"Insua-Rodr\u00edguez","year":"2026"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.cd-21-0211","article-title":"Cholesterol auxotrophy as a targetable vulnerability in clear cell renal cell carcinoma","volume":"11","author":"Riscal","year":"2021","journal-title":"Cancer Discov"},{"key":"B46","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1186\/s13578-023-01138-9","article-title":"Glycolysis-cholesterol metabolic axis in immuno-oncology microenvironment: emerging role in immune cells and immunosuppressive signaling","volume":"13","author":"Jin","year":"2023","journal-title":"Cell Bioscience"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1126\/science.abf9419","article-title":"Tertiary lymphoid structures in cancer","volume":"375","author":"Schumacher","year":"2022","journal-title":"Science"},{"key":"B48","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1038\/s43018-021-00232-6","article-title":"Mature tertiary lymphoid structures predict immune checkpoint inhibitor efficacy in solid tumors independently of PD-L1 expression","volume":"2","author":"Vanhersecke","year":"2021","journal-title":"Nat Cancer"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2014.09.006","article-title":"Tertiary lymphoid structures in cancer and beyond","volume":"35","author":"Dieu-Nosjean","year":"2014","journal-title":"Trends Immunol"},{"key":"B50","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/s41392-024-01947-5","article-title":"Tertiary lymphoid structures in diseases: immune mechanisms and therapeutic advances","volume":"9","author":"Zhao","year":"2024","journal-title":"Signal Transduction Targeted Ther"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1080\/2162402x.2025.2528109","article-title":"Mature tertiary lymphoid structures linked to HPV status and anti-PD-1 based chemoimmunotherapy response in head and neck squamous cell carcinoma","volume":"14","author":"Zhang","year":"2025","journal-title":"Oncoimmunology"},{"key":"B52","doi-asserted-by":"crossref","DOI":"10.1101\/2023.10.16.562104","article-title":"Immune landscape of tertiary lymphoid structures in hepatocellular carcinoma (HCC) treated with neoadjuvant immune checkpoint blockade","volume-title":"Biorxiv","author":"Shu","year":"2023"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1922-8","article-title":"B cells and tertiary lymphoid structures promote immunotherapy response","volume":"577","author":"Helmink","year":"2020","journal-title":"Nature"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1038\/nature17947","article-title":"EBI2 augments Tfh cell fate by promoting interaction with IL-2-quenching dendritic cells","volume":"533","author":"Li","year":"2016","journal-title":"Nature"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.can-21-0101","article-title":"Characterizing macrophage diversity in metastasis-bearing lungs reveals a lipid-associated macrophage subset","volume":"81","author":"Huggins","year":"2021","journal-title":"Cancer Res"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1016\/j.tem.2017.03.002","article-title":"The role of oxysterols in human cancer","volume":"28","author":"Kloudova","year":"2017","journal-title":"Trends Endocrinol Metab"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1038\/nature10280","article-title":"Oxysterols direct immune cell migration via EBI2","volume":"475","author":"Hannedouche","year":"2011","journal-title":"Nature"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1111\/imr.70088","article-title":"Peripheral helper cells in lymphoid aggregate and tertiary lymphoid structure formation","volume":"337","author":"Sowerby","year":"2026","journal-title":"Immunol Rev"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20252667","article-title":"Sensing of metabolic signals via GPR183 promotes occupation of lung macrophage niches by monocytes","volume":"223","author":"Bub","year":"2026","journal-title":"J Exp Med"},{"key":"B60","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1146\/annurev-immunol-032713-120145","article-title":"Chemokines and chemokine receptors: positioning cells for host defense and immunity","volume":"32","author":"Griffith","year":"2014","journal-title":"Annu Rev Immunol"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1096\/fj.12-208876","article-title":"EBI2 regulates CXCL13\u2010mediated responses by heterodimerization with CXCR5","volume":"26","author":"Barroso","year":"2012","journal-title":"FASEB J"},{"key":"B62","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/s41408-021-00459-7","article-title":"CAR-T cell therapy: current limitations and potential strategies","volume":"11","author":"Sterner","year":"2021","journal-title":"Blood Cancer J"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2016.04.010","article-title":"Targeting immunosuppressive myeloid cells using nanocarriers to improve cancer immunotherapy","volume":"96","author":"Sasso","year":"2015","journal-title":"Biomaterials"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00128","article-title":"CAR T cells for solid tumors: new strategies for finding, infiltrating, and surviving in the tumor microenvironment","volume":"10","author":"Martinez","year":"2019","journal-title":"Front Immunol"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-021-00541-y","article-title":"Metabolic barriers to cancer immunotherapy","volume":"21","author":"DePeaux","year":"2021","journal-title":"Nat Rev Immunol"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdx238","article-title":"Mechanisms regulating T-cell infiltration and activity in solid tumors","volume":"28","author":"Lanitis","year":"2017","journal-title":"Ann Oncol"},{"key":"B67","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1126\/science.aaa6204","article-title":"T cell exclusion, immune privilege, and the tumor microenvironment","volume":"348","author":"Joyce","year":"2015","journal-title":"Science"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2020.09.015","article-title":"CAR T cell therapy for solid tumors: bright future or dark reality","volume":"28","author":"Wagner","year":"2020","journal-title":"Mol Ther"},{"key":"B69","doi-asserted-by":"publisher","first-page":"2548","DOI":"10.7150\/ijbs.34213","article-title":"Current progress in CAR-T cell therapy for solid tumors","volume":"15","author":"Ma","year":"2019","journal-title":"Int J Biol Sci"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-019-0297-y","article-title":"Engineering strategies to overcome the current roadblocks in CAR T cell therapy","volume":"17","author":"Rafiq","year":"2020","journal-title":"Nat Rev Clin Oncol"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2017.01.016","article-title":"The principles of engineering immune cells to treat cancer","volume":"168","author":"Lim","year":"2017","journal-title":"Cell"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2016.01.011","article-title":"Precision tumor recognition by T cells with combinatorial antigen-sensing circuits","volume":"164","author":"Roybal","year":"2016","journal-title":"Cell"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.ccr-11-0351","article-title":"Expression of a functional CCR2 receptor enhances tumor localization and tumor eradication by retargeted human T cells expressing a mesothelin-specific chimeric antibody receptor","volume":"17","author":"Moon","year":"2011","journal-title":"Clin Cancer Res"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-03-209650","article-title":"T lymphocytes coexpressing CCR4 and a chimeric antigen receptor targeting CD30 have improved homing and antitumor activity in a Hodgkin tumor model","volume":"113","author":"Di Stasi","year":"2009","journal-title":"Blood J Am Soc Hematol"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3833","article-title":"Heparanase promotes tumor infiltration and antitumor activity of CAR-redirected T lymphocytes","volume":"21","author":"Caruana","year":"2015","journal-title":"Nat Med"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-med-062315-120245","article-title":"CAR T cell therapy for solid tumors","volume":"68","author":"Newick","year":"2017","journal-title":"Annu Rev Med"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1097\/PPO.0000000000000032","article-title":"CAR T cells for solid tumors: armed and ready to go","volume":"20","author":"Kakarla","year":"2014","journal-title":"Cancer J"},{"key":"B78","doi-asserted-by":"publisher","first-page":"10541","DOI":"10.1038\/s41598-017-10940-8","article-title":"Armored CAR T cells enhance antitumor efficacy and overcome the tumor microenvironment","volume":"7","author":"Yeku","year":"2017","journal-title":"Sci Rep"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1016\/s1074-7613(00)80170-3","article-title":"Abrogation of TGFbeta signaling in T cells leads to spontaneous T cell differentiation and autoimmune disease","volume":"12","author":"Gorelik","year":"2000","journal-title":"Immunity"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1016\/s1074-7613(00)80089-8","article-title":"Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor","volume":"11","author":"Nishimura","year":"1999","journal-title":"Immunity"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)30764-0","article-title":"Pexidartinib versus placebo for advanced tenosynovial giant cell tumour (ENLIVEN): a randomised phase 3 trial","volume":"394","author":"Tap","year":"2019","journal-title":"Lancet"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1038\/ni1309","article-title":"Monocyte emigration from bone marrow during bacterial infection requires signals mediated by chemokine receptor CCR2","volume":"7","author":"Serbina","year":"2006","journal-title":"Nat Immunol"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1038\/nbt.4086","article-title":"IL-7 and CCL19 expression in CAR-T cells improves immune cell infiltration and CAR-T cell survival in the tumor","volume":"36","author":"Adachi","year":"2018","journal-title":"Nat Biotechnol"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1021\/jm4019355","article-title":"Identification and characterization of small molecule modulators of the Epstein\u2013Barr virus-induced gene 2 (EBI2) receptor","volume":"57","author":"Gessier","year":"2014","journal-title":"J Med Chem"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1007\/s11030-024-10811-1","article-title":"First report on chemometrics-driven multilayered lead prioritization in addressing oxysterol-mediated overexpression of G protein-coupled receptor 183","volume":"28","author":"Bhattacharjee","year":"2024","journal-title":"Mol Divers"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2017.01.020","article-title":"EBI2 is highly expressed in multiple sclerosis lesions and promotes early CNS migration of encephalitogenic CD4 T cells","volume":"18","author":"Wanke","year":"2017","journal-title":"Cell Rep"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1002\/CMDC.202100301","article-title":"Discovery of GPR183 agonists based on an antagonist scaffold","volume":"16","author":"Kj\u00e6r","year":"2021","journal-title":"ChemMedChem"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1161\/circresaha.124.324722","article-title":"Oxysterol sensing through GPR183 triggers endothelial senescence in hypertension","volume":"135","author":"Chu","year":"2024","journal-title":"Circ Res"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.120.000105","article-title":"GPR183-oxysterol axis in spinal cord contributes to neuropathic pain","volume":"375","author":"Braden","year":"2020","journal-title":"J Pharmacol Exp Ther"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1002\/ctd2.70119","article-title":"GPR183\u2010mediated activation of PI3K is a potential biomarker for immunotherapy in lung cancer","volume":"6","author":"Ye","year":"2026","journal-title":"Clin Trans Discov"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1002\/eji.201444493","article-title":"Oxysterol\u2010EBI2 signaling in immune regulation and viral infection","volume":"44","author":"Daugvilaite","year":"2014","journal-title":"Eur J Immunol"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2009.05.006","article-title":"GPS2 is required for cholesterol efflux by triggering histone demethylation, LXR recruitment, and coregulator assembly at the ABCG1 locus","volume":"34","author":"Jakobsson","year":"2009","journal-title":"Mol Cell"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1002\/mog2.95","article-title":"KMT2C\/D deficiency promotes breast cancer metastasis by regulating KDM6A\u2010mediated epigenetic remodeling","volume":"3","author":"Huang","year":"2024","journal-title":"MedComm-Oncology"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1931992\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T10:18:35Z","timestamp":1789553915000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1931992\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,16]]},"references-count":93,"alternative-id":["10.3389\/fimmu.2026.1931992"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1931992","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,16]]},"article-number":"1931992"}}